Journal Home
Search for

Volume 92, Issue 3, Pages 913-917 (September 2009)


View previous. 16 of 69 View next.

Live birth sex ratios are not influenced by blastocyst-stage embryo transfer

John M. Csokmay, M.D.a, Micah J. Hill, D.O.b, Frank V. Cioppettinic, Kathleen A. Miller, BSc, Richard T. Scott Jr., M.D., HCLDc, John L. Frattarelli, M.D.cCorresponding Author Informationemail address

Received 29 February 2008; received in revised form 1 June 2008; accepted 10 July 2008. published online 09 September 2008.

Objective

To analyze the sex ratio of infants born after blastocyst-stage transfer of embryos with normal preimplantation FISH genetic screening.

Design

Retrospective cohort analysis.

Setting

Large academic assisted reproductive technology center.

Patient(s)

Two hundred twenty-eight patients undergoing fresh IVF cycle with blastocyst transfer.

Intervention(s)

Preimplantation genetic screening for sex complement.

Main Outcome Measure(s)

Sex ratio in liveborn infants following blastocyst transfer.

Result(s)

One thousand thirteen embryos were normal by preimplantation genetic screening of chromosomes 13, 15, 16, 17, 18, 21, 22, X, and Y. Four hundred ninety-eight normal embryos were transferred to 228 patients with an overall live birth rate of 41.7%. Transferred blastocysts were selected based upon morphologic assessment. When controlling for the sex of the blastocyst embryo, there was no difference in the male-to-female delivery rate per embryo transferred (27.3% vs. 21.4%) (relative risk =1.28, confidence interval 0.93–1.74). Of the live births 51.7% were male and 48.3% were female (P=.61). Subanalysis revealed no difference in male-to-female delivery rates in groups with a 1:1 ratio of male:female embryos transferred, a non 1:1 ratio transferred, or single-sex transfers.

Conclusion(s)

Blastocyst-stage embryo transfer does not influence the live birth sex ratio of embryos with normal preimplantation FISH genetic screening.

a National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland

b Blanchfield Army Community Hospital, Ft. Campbell, Kentucky

c Reproductive Medicine Associates of New Jersey, Morristown, New Jersey

Corresponding Author InformationReprint requests: John L. Frattarelli, M.D., Reproductive Medicine Associates of New Jersey, 111 Madison Avenue, Suite 100, Morristown, NJ 07960 (FAX: 732-537-0134).

 J.M.C. has nothing to disclose. M.J.H. has nothing to disclose. F.V.C. has nothing to disclose. K.A.M. has nothing to disclose. R.T.S. has nothing to disclose. J.L.F. has nothing to disclose.

PII: S0015-0282(08)03262-7

doi:10.1016/j.fertnstert.2008.07.1741


View previous. 16 of 69 View next.